135 related articles for article (PubMed ID: 35122901)
21. Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis : Two Nationwide Cohort Studies.
Gaber CE; Kinlaw AC; Edwards JK; Lund JL; Stürmer T; Peacock Hinton S; Pate V; Bartelt LA; Sandler RS; Peery AF
Ann Intern Med; 2021 Jun; 174(6):737-746. PubMed ID: 33617725
[TBL] [Abstract][Full Text] [Related]
22. Safety of topical ophthalmic antibiotics in pregnant women with hordeola, chalazia, blepharitis, or bacterial conjunctivitis: propensity score analyses.
Hashimoto Y; Michihata N; Yamana H; Shigemi D; Morita K; Matsui H; Yasunaga H; Aihara M
Eye (Lond); 2022 May; 36(5):1066-1073. PubMed ID: 34035495
[TBL] [Abstract][Full Text] [Related]
23. The Relative Risk of Achilles Tendon Injury in Patients Taking Quinolones.
Jupiter DC; Fang X; Ashmore Z; Shibuya N; Mehta HB
Pharmacotherapy; 2018 Sep; 38(9):878-887. PubMed ID: 29972705
[TBL] [Abstract][Full Text] [Related]
24. Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study.
Ernst P; Dahl M; Chateau D; Daneman N; Quail J; Sketris IS; Fisher A; Zhang J; Bugden S;
Int J Chron Obstruct Pulmon Dis; 2019; 14():2939-2946. PubMed ID: 31908442
[TBL] [Abstract][Full Text] [Related]
25. Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.
Zhou M; Wang SV; Leonard CE; Gagne JJ; Fuller C; Hampp C; Archdeacon P; Toh S; Iyer A; Woodworth TS; Cavagnaro E; Panozzo CA; Axtman S; Carnahan RM; Chrischilles EA; Hennessy S
Epidemiology; 2017 Nov; 28(6):838-846. PubMed ID: 28682851
[TBL] [Abstract][Full Text] [Related]
26. Fluoroquinolone use and serious arrhythmias: A nationwide case-crossover study.
Porta L; Lee MG; Hsu WT; Hsu TC; Tsai TY; Lee CC
Resuscitation; 2019 Jun; 139():262-268. PubMed ID: 31029713
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
LaPlante KL; Mersfelder TL; Ward KE; Quilliam BJ
Pharmacotherapy; 2008 Jan; 28(1):82-9. PubMed ID: 18154478
[TBL] [Abstract][Full Text] [Related]
28. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.
Lee CC; Lee MT; Chen YS; Lee SH; Chen YS; Chen SC; Chang SC
JAMA Intern Med; 2015 Nov; 175(11):1839-47. PubMed ID: 26436523
[TBL] [Abstract][Full Text] [Related]
29. Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis.
Pham Nguyen TP; Leonard CE; Bird SJ; Willis AW; Hamedani AG
Muscle Nerve; 2021 Aug; 64(2):156-162. PubMed ID: 33719062
[TBL] [Abstract][Full Text] [Related]
30. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).
Effa EE; Lassi ZS; Critchley JA; Garner P; Sinclair D; Olliaro PL; Bhutta ZA
Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD004530. PubMed ID: 21975746
[TBL] [Abstract][Full Text] [Related]
31. Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
Dong YH; Chang CH; Wang JL; Wu LC; Lin JW; Toh S
JAMA Intern Med; 2020 Dec; 180(12):1587-1595. PubMed ID: 32897358
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of disability in patients exposed to fluoroquinolones.
Wilcox MA; Villasis-Keever A; Sena AG; Knoll C; Fife D
BMC Pharmacol Toxicol; 2020 Jun; 21(1):40. PubMed ID: 32493505
[TBL] [Abstract][Full Text] [Related]
33. Oral Fluoroquinolone and the Risk of Aortic Dissection.
Lee CC; Lee MG; Hsieh R; Porta L; Lee WC; Lee SH; Chang SS
J Am Coll Cardiol; 2018 Sep; 72(12):1369-1378. PubMed ID: 30213330
[TBL] [Abstract][Full Text] [Related]
34. Gatifloxacin-associated hypoglycemia.
Ali T; Greenfield RA; Scofield H; Bronze MS
J Okla State Med Assoc; 2007 Nov; 100(11):425-8. PubMed ID: 18183859
[TBL] [Abstract][Full Text] [Related]
35. Association Between Use of Fluoroquinolones and Risk of Mitral or Aortic Valve Regurgitation: A Nationwide Cohort Study.
Dong YH; Wang JL; Chang CH; Lin JW; Chen YA; Chen CY; Toh S
Clin Pharmacol Ther; 2024 Jan; 115(1):147-157. PubMed ID: 37926942
[TBL] [Abstract][Full Text] [Related]
36. Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study.
Wang J; Gagne JJ; Kattinakere-Sreedhara S; Fischer MA; Bykov K
BMJ; 2022 Oct; 379():e069931. PubMed ID: 36195324
[TBL] [Abstract][Full Text] [Related]
37. The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea.
Novell MJ; Morreale CA
Ann Pharmacother; 2010 May; 44(5):826-31. PubMed ID: 20354161
[TBL] [Abstract][Full Text] [Related]
38. Fluoroquinolones and the risk of serious arrhythmia: a population-based study.
Lapi F; Wilchesky M; Kezouh A; Benisty JI; Ernst P; Suissa S
Clin Infect Dis; 2012 Dec; 55(11):1457-65. PubMed ID: 22865870
[TBL] [Abstract][Full Text] [Related]
39. Risk of acute kidney injury associated with the use of fluoroquinolones.
Bird ST; Etminan M; Brophy JM; Hartzema AG; Delaney JA
CMAJ; 2013 Jul; 185(10):E475-82. PubMed ID: 23734036
[TBL] [Abstract][Full Text] [Related]
40. Severe dysglycemia with the fluoroquinolones: a class effect?
Aspinall SL; Good CB; Jiang R; McCarren M; Dong D; Cunningham FE
Clin Infect Dis; 2009 Aug; 49(3):402-8. PubMed ID: 19545207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
